KevinToh
2022-12-04
//@Kelvinphan:Go//@daz888888888:$Rigel Pharmaceuticals(RIGL)$  Insiders who bought Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) stock in the last 12 months were richly rewarded last week. The company's market value increased by US$14m as a result of the stock's 11% gain over the same period. As a result, the stock they originally bought for US$688k is now worth US$834k. While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
8